Gene · 274
Papers2,900
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,900
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An overview of human single-cell RNA sequencing studies in neurobiological disease. | Neurobiol Dis | 2023 | 37321420 | PubTator, text mining | PubMed |
| Utility of DNA Methylation as a Biomarker in Aging and Alzheimer's Disease. | J Alzheimers Dis Rep | 2023 | 37313495 | PubTator, text mining | PubMed |
| Species-Deconvolved Proteomics for In Situ Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Cancer Patient-Derived Xenografts with Combined Gemcitabine and Paclitaxel. | J Proteome Res | 2023 | 37311110 | PubTator, text mining | PubMed |
| GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy. | J Mov Disord | 2023 | 37302978 | PubTator, text mining | PubMed |
| The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer's Disease Mouse Model. | Int J Mol Sci | 2023 | 37298634 | PubTator, text mining | PubMed |
| Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease. | Int J Mol Sci | 2023 | 37298224 | PubTator, text mining | PubMed |
| A review of current evidence for mild behavioral impairment as an early potential novel marker of Alzheimer's disease. | Front Psychiatry | 2023 | 37293396 | PubTator, text mining | PubMed |
| 3D-bioprinting of patient-derived cardiac tissue models for studying congenital heart disease. | Front Cardiovasc Med | 2023 | 37293290 | PubTator, text mining | PubMed |
| Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease). | Alzheimers Dement (N Y) | 2023 | 37287472 | PubTator, text mining | PubMed |
| Six mitophagy-related hub genes as peripheral blood biomarkers of Alzheimer's disease and their immune cell infiltration correlation. | Front Neurosci | 2023 | 37274215 | PubTator, text mining | PubMed |
| Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. | Mol Ther Nucleic Acids | 2023 | 37273786 | PubTator, text mining | PubMed |
| Alzheimer's disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs. | Front Mol Neurosci | 2023 | 37266374 | PubTator, text mining | PubMed |
| Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders. | Pharmaceuticals (Basel) | 2023 | 37259364 | PubTator, text mining | PubMed |
| Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease. | Brain | 2023 | 37247383 | PubTator, text mining | PubMed |
| High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients. | Asian Pac J Cancer Prev | 2023 | 37247278 | PubTator, text mining | PubMed |
| Potential Role of Protein Kinase FAM20C on the Brain in Raine Syndrome, an In Silico Analysis. | Int J Mol Sci | 2023 | 37240249 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid-Basic Concepts Review. | Biomedicines | 2023 | 37239132 | PubTator, text mining | PubMed |
| A Preliminary Comparison of the Methylome and Transcriptome from the Prefrontal Cortex Across Alzheimer's Disease and Lewy Body Dementia. | J Alzheimers Dis Rep | 2023 | 37220618 | PubTator, text mining | PubMed |
| Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. | Mol Biol Rep | 2023 | 37217614 | PubTator, text mining | PubMed |
| Small extracellular vesicle-mediated metabolic reprogramming: from tumors to pre-metastatic niche formation. | Cell Commun Signal | 2023 | 37208722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/274/papers?page=17